A citation-based method for searching scientific literature


List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.
C Bethan Powell, Lee-may Chen, Jane McLennan, Beth Crawford, Charles Zaloudek, Joseph T Rabban, Dan H Moore, John Ziegler. Int J Gynecol Cancer 2011
104
60

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Amy Finch, Patricia Shaw, Barry Rosen, Joan Murphy, Steven A Narod, Terence J Colgan. Gynecol Oncol 2006
259
40


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
40

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
40

High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.
Jane E Hirst, Gregory B Gard, Kirsty McIllroy, David Nevell, Michael Field. Int J Gynecol Cancer 2009
48
40

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
73
40

Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
L Minig, S Cabrera, R Oliver, A Couso, M J Rubio, S Iacoponi, M B Martin-Salamanca, S Carballo-Rastrilla, J M Cádenas-Rebollo, A García-Garcia,[...]. Clin Transl Oncol 2018
7
40

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Julie D Lamb, Rochelle L Garcia, Barbara A Goff, Pamela J Paley, Elizabeth M Swisher. Am J Obstet Gynecol 2006
66
40

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
561
40

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Mark E Sherman, Marion Piedmonte, Phuong L Mai, Olga B Ioffe, Brigitte M Ronnett, Linda Van Le, Iouri Ivanov, Maria C Bell, Stephanie V Blank, Paul DiSilvestro,[...]. J Clin Oncol 2014
78
40

Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes.
Claire Thompson, Ciara McCormick, Waseem Kamran, Ciaran O'Riain, Lucy Norris, David Gallagher, Noreen Gleeson. Ir J Med Sci 2018
6
40

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.
Mae Zakhour, Yael Danovitch, Jenny Lester, B J Rimel, Christine S Walsh, Andrew J Li, Beth Y Karlan, Ilana Cass. Gynecol Oncol 2016
45
40


Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Stephanie L Wethington, Kay J Park, Robert A Soslow, Noah D Kauff, Carol L Brown, Fanny Dao, Ebunoluwa Otegbeye, Yukio Sonoda, Nadeem R Abu-Rustum, Richard R Barakat,[...]. Int J Gynecol Cancer 2013
67
40

Effectiveness of risk-reducing salpingo-oophorectomy in preventing ovarian cancer in a high-risk French Canadian population.
Omar Moreira Bacha, Jean Gregoire, Katherine Grondin, Maria Isabel Edelweiss, Rachel Laframboise, Jacques Simard, Marie Plante. Int J Gynecol Cancer 2012
7
40

Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.
Marjanka J J M Mingels, Thijs Roelofsen, Jeroen A W M van der Laak, Joanne A de Hullu, Maaike A P C van Ham, Leon F A G Massuger, Johan Bulten, Mijke Bol. Gynecol Oncol 2012
52
40

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
James R Conner, Emily Meserve, Ellen Pizer, Judy Garber, Michael Roh, Nicole Urban, Charles Drescher, Bradley J Quade, Michael Muto, Brooke E Howitt,[...]. Gynecol Oncol 2014
56
40

Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Valentina Chiappa, Maria Luisa Carcangiu, Biagio Paolini, Jvan Casarin, Cono Scaffa, Massimiliano Gennaro, Fabio Martinelli,[...]. J Minim Invasive Gynecol 2017
11
40

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.
Anais Malpica, Elizabeth D Euscher, Jonathan L Hecht, Rouba Ali-Fehmi, Charles M Quick, Naveena Singh, Lars-Christian Horn, Isabel Alvarado-Cabrero, Xavier Matias-Guiu, Lynn Hirschowitz,[...]. Int J Gynecol Pathol 2019
26
40

Prevalence of Appendiceal Lesions in Appendicectomies Performed During Surgery for Mucinous Ovarian Tumors: A Retrospective Study.
Luiza Moore, Ketan Gajjar, Mercedes Jimenez-Linan, Robin Crawford. Int J Gynecol Cancer 2016
4
25

Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases.
Colin J R Stewart, Barbara A Brennan, Ian G Hammond, Yee C Leung, Anthony J McCartney. Int J Gynecol Pathol 2006
62
20




Secondary ovarian malignancies: frequency, origin, and characteristics.
Yvonne R P de Waal, Chris M G Thomas, Angèle L M Oei, Fred C G J Sweep, Leon F A G Massuger. Int J Gynecol Cancer 2009
61
20


Prognostic implication of endometriosis in clear cell carcinoma of the ovary.
J P Orezzoli, A H Russell, E Oliva, M G Del Carmen, J Eichhorn, A F Fuller. Gynecol Oncol 2008
70
20


Ovarian disease in women with breast cancer.
J P Curtin, R R Barakat, W J Hoskins. Obstet Gynecol 1994
58
20

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Robert A Soslow, Guangming Han, Kay J Park, Karuna Garg, Narciso Olvera, David R Spriggs, Noah D Kauff, Douglas A Levine. Mod Pathol 2012
122
20


Endometriosis-associated ovarian neoplasia.
Xavier Matias-Guiu, Colin J R Stewart. Pathology 2018
49
20


Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Brigitte M Ronnett, Anna V Yemelyanova, Russell Vang, C Blake Gilks, Dianne Miller, Patti E Gravitt, Robert J Kurman. Am J Surg Pathol 2008
88
20

The role of appendectomy for mucinous ovarian neoplasms.
Jennifer E Lin, Songwon Seo, David M Kushner, Stephen L Rose. Am J Obstet Gynecol 2013
28
20

Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
Hiroaki Kajiyama, Kiyosumi Shibata, Shiro Suzuki, Kazuhiko Ino, Eiko Yamamoto, Kimio Mizuno, Katsumi Sakakibara, Katsuji Matsuzawa, Akihiro Takeda, Yoshito Kinoshita,[...]. Gynecol Oncol 2008
23
20

A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
Ting Gui, Dongyan Cao, Keng Shen, Jiaxin Yang, Yiwen Zhang, Qi Yu, Xirun Wan, Yang Xiang, Yu Xiao, Lina Guo. Gynecol Oncol 2012
66
20

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
John K Chan, Deanna Teoh, Jessica M Hu, Jacob Y Shin, Kathryn Osann, Daniel S Kapp. Gynecol Oncol 2008
266
20

Ovarian atypical endometriosis: its close association with malignant epithelial tumours.
M Fukunaga, K Nomura, E Ishikawa, S Ushigome. Histopathology 1997
228
20

Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis.
K Houck, N Nikrui, L Duska, Y Chang, A F Fuller, D Bell, A Goodman. Obstet Gynecol 2000
88
20

Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review.
Paraskevi Savvari, Panagiotis Peitsidis, Maria Alevizaki, Meletios-A Dimopoulos, Aristidis Antsaklis, Christos A Papadimitriou. Onkologie 2009
26
20

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.
S Ogawa, T Kaku, S Amada, H Kobayashi, T Hirakawa, K Ariyoshi, T Kamura, H Nakano. Gynecol Oncol 2000
177
20


Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
Cristina Sigismondi, Angiolo Gadducci, Domenica Lorusso, Massimo Candiani, Enrico Breda, Francesco Raspagliesi, Gennaro Cormio, Marco Marinaccio, Giorgia Mangili. Gynecol Oncol 2012
44
20

Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayse Ayhan, Tsui-Lien Mao, Tamer Seckin, Chen-Hsuan Wu, Bin Guan, Hiroshi Ogawa, Masayuki Futagami, Hiroki Mizukami, Yoshihito Yokoyama, Robert J Kurman,[...]. Int J Gynecol Cancer 2012
99
20

Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: is it possible?
Hiroaki Kajiyama, Kiyosumi Shibata, Mika Mizuno, Satoyo Hosono, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka Kikkawa. Hum Reprod 2011
40
20



Secondary ovarian neoplasia. A clinicopathologic study of 35 cases.
T M Ulbright, L M Roth, F B Stehman. Cancer 1984
151
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.